semaglutide and creatinine lowers UACR in overweight CKD patients Semaglutide in kidney outcomes Obesity

With an estimated 1,000,000 and 3,000,000 Americans impacted , and 25% of which are disabled and unable to work, this diagnosis can be devastating for many of our patients. Theres more hope than just managing POTS symptoms, though

These medications, commonly prescribed for diabetes and weight management, can significantly impact your appetite and how your body processes food

Common side effects are nausea, vomiting, diarrhea, and constipation

Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14

If you came to me and had high blood pressure and I put you on a medicine, once your blood pressure got normal, would you stop taking it

Here is what the July 30 deadline means if you are on a compounded GLP-1